{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:05:42Z","timestamp":1781629542627,"version":"3.54.5"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Oral Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The early diagnosis of odontogenic cysts is crucial to prevent future complications and to choose an effective treatment plan. Dentigerous cysts (DCs) and odontogenic keratocysts (OKCs) are two common developmental cysts that affect the jaw. OKCs show locally aggressive behavior and a higher recurrence rate compared with DCs, emphasizing the need for reliable molecular diagnostic markers. MicroRNAs (miRNAs) are abnormally expressed in tumors and lesions with aggressive behavior and have potential as adjunctive biomarkers. This study investigates the diagnostic potential of miR-221, miR-214, and miR-375 expression in OKCs and DCs, due to the invasive nature of OKCs compared with DCs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>This study analyzed 36 paraffin-embedded odontogenic cyst tissue samples (23 OKC and 13 DC) collected from the oral pathology archive of Islamic Azad University. Total RNA, including miRNAs, was extracted using TRIzol-based protocols with RNase-free conditions. RNA purity and integrity were assessed via spectrophotometry and agarose gel electrophoresis. Reverse transcription was performed using the M-MLV RNase H kit. Specific primers for miR-221, miR-214, and miR-375 were designed and verified. Quantitative real-time PCR was conducted using SYBR Green, and delta cycle threshold (\u0394Ct) values were calculated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      miR-221, miR-214, and miR-375 showed significantly lower \u0394Ct values in OKCs compared with DCs (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). The mean \u0394Ct values for miR-221, miR-214, and miR-375 in OKCs were 11.27, 10.10, and 8.18, respectively, compared with 12.95, 12.51, and 11.05 in DCs.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The \u0394Ct values for miR-221, miR-214, and miR-375s were significantly lower in OKC samples, indicating higher expression levels compared with DCs. The significant upregulation of these miRNAs in OKCs compared with DCs suggests that these miRNAs may indicate predictive roles and could serve as supportive biomarkers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12903-025-07289-0","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T10:46:38Z","timestamp":1765536398000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Expression patterns of miR-221, miR-214, and miR-375 in odontogenic keratocysts versus dentigerous cysts: an in vitro comparison"],"prefix":"10.1186","volume":"25","author":[{"given":"Sareh","family":"Farhadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maliheh","family":"Entezari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorsa","family":"Abdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salar","family":"Mirzaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina Noruozian","family":"Fard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana","family":"Baghizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"issue":"s1","key":"7289_CR1","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1038\/modpathol.2016.191","volume":"30","author":"RA Robinson","year":"2017","unstructured":"Robinson RA. Diagnosing the most common odontogenic cystic and osseous lesions of the jaws for the practicing pathologist. Mod Pathol. 2017;30(s1):S96\u2013103.","journal-title":"Mod Pathol"},{"issue":"1","key":"7289_CR2","doi-asserted-by":"publisher","first-page":"249","DOI":"10.31557\/APJCP.2019.20.1.249","volume":"20","author":"A Ali","year":"2019","unstructured":"Ali A, Asif M, Ahmad B, Jamal S, Ali I, Khadim MT. Stromal expression of CD10 by immunohistochemistry in odontogenic keratocyst (OKC), dentigerous and radicular cysts and its correlation with local recurrence and aggressive behaviour. Asian Pac J Cancer Prev. 2019;20(1):249\u201353.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"8","key":"7289_CR3","volume":"16","author":"P Batra","year":"2024","unstructured":"Batra P, Batra SG, Ahuja D, Batra R. Management and rehabilitation of dentigerous cyst with 10-year follow-up: a case report. Cureus. 2024;16(8):e67867.","journal-title":"Cureus"},{"issue":"1","key":"7289_CR4","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.4317\/medoral.17088","volume":"17","author":"A A\u00e7ikg\u00f6z","year":"2012","unstructured":"A\u00e7ikg\u00f6z A, Uzun-Bulut E, \u00d6zden B, G\u00fcnd\u00fcz K. Prevalence and distribution of odontogenic and nonodontogenic cysts in a Turkish population. Med Oral Patol Oral Cir Bucal. 2012;17(1):e108-15.","journal-title":"Med Oral Patol Oral Cir Bucal"},{"issue":"Suppl 1","key":"7289_CR5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s12663-011-0172-6","volume":"14","author":"CM Contar","year":"2015","unstructured":"Contar CM, Thom\u00e9 CA, Pompermayer A, Sarot JR, Vinagre RO, Machado M. Marsupialization of dentigerous cyst: report of a case. J Maxillofac Oral Surg. 2015;14(Suppl 1):4\u20136.","journal-title":"J Maxillofac Oral Surg"},{"issue":"1","key":"7289_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12903-021-01542-y","volume":"21","author":"M Nahajowski","year":"2021","unstructured":"Nahajowski M, Hnitecka S, Antoszewska-Smith J, Rumin K, Dubowik M, Sarul M. Factors influencing an eruption of teeth associated with a dentigerous cyst: a systematic review and meta-analysis. BMC Oral Health. 2021;21(1):180.","journal-title":"BMC Oral Health"},{"key":"7289_CR7","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.ijscr.2020.10.059","volume":"76","author":"A Marchal","year":"2020","unstructured":"Marchal A, G\u00e9rard \u00c9, Curien R, Bourgeois G. Primary intraosseous carcinoma arising in dentigerous cyst: case report. Int J Surg Case Rep. 2020;76:530\u20133.","journal-title":"Int J Surg Case Rep"},{"issue":"5","key":"7289_CR8","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s13244-018-0644-z","volume":"9","author":"A Borghesi","year":"2018","unstructured":"Borghesi A, Nardi C, Giannitto C, Tironi A, Maroldi R, Di Bartolomeo F, et al. Odontogenic keratocyst: imaging features of a benign lesion with an aggressive behaviour. Insights Imaging. 2018;9(5):883\u201397.","journal-title":"Insights Imaging"},{"issue":"7","key":"7289_CR9","doi-asserted-by":"publisher","first-page":"e364","DOI":"10.1016\/j.jcms.2014.03.020","volume":"42","author":"GN Antonoglou","year":"2014","unstructured":"Antonoglou GN, S\u00e1ndor GK, Koidou VP, Papageorgiou SN. Non-syndromic and syndromic keratocystic odontogenic tumors: systematic review and meta-analysis of recurrences. J Craniomaxillofac Surg. 2014;42(7):e364-71.","journal-title":"J Craniomaxillofac Surg"},{"key":"7289_CR10","volume":"7","author":"S Tamgadge","year":"2013","unstructured":"Tamgadge S, Tamgadge A, Modak N, Bhalerao S. Primary intraosseous squamous cell carcinoma arising from an odontogenic keratocyst: a case report and literature review. Ecancermedicalscience. 2013;7:316.","journal-title":"Ecancermedicalscience"},{"issue":"2","key":"7289_CR11","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP. Micrornas: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281\u201397.","journal-title":"Cell"},{"issue":"7006","key":"7289_CR12","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nature02871","volume":"431","author":"V Ambros","year":"2004","unstructured":"Ambros V. The functions of animal MicroRNAs. Nature. 2004;431(7006):350\u20135.","journal-title":"Nature"},{"issue":"1","key":"7289_CR13","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1101\/gr.082701.108","volume":"19","author":"RC Friedman","year":"2009","unstructured":"Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009;19(1):92\u2013105.","journal-title":"Genome Res"},{"issue":"10","key":"7289_CR14","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1111\/febs.16422","volume":"290","author":"P Naeli","year":"2023","unstructured":"Naeli P, Winter T, Hackett AP, Alboushi L, Jafarnejad SM. The intricate balance between microRNA-induced mRNA decay and translational repression. FEBS J. 2023;290(10):2508\u201324.","journal-title":"FEBS J"},{"issue":"1","key":"7289_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-025-03391-x","volume":"44","author":"MTD Martino","year":"2025","unstructured":"Martino MTD, Tagliaferri P, Tassone P. Microrna in cancer therapy: breakthroughs and challenges in early clinical applications. J Exp Clin Cancer Res. 2025;44(1):126.","journal-title":"J Exp Clin Cancer Res"},{"issue":"9","key":"7289_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10092121","volume":"10","author":"TTP Nguyen","year":"2022","unstructured":"Nguyen TTP, Suman KH, Nguyen TB, Nguyen HT, Do DN. The role of miR-29s in human cancers\u2014an update. Biomedicines. 2022;10(9):2121.","journal-title":"Biomedicines"},{"issue":"2","key":"7289_CR17","first-page":"533","volume":"42","author":"Z Wang","year":"2019","unstructured":"Wang Z, Gao L, Guo X, Feng C, Deng K, Lian W, et al. Identification of MicroRNAs associated with the aggressiveness of prolactin pituitary tumors using bioinformatic analysis. Oncol Rep. 2019;42(2):533\u201348.","journal-title":"Oncol Rep"},{"issue":"1","key":"7289_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-42392-7","volume":"9","author":"Y Akazawa","year":"2019","unstructured":"Akazawa Y, Mizuno S, Fujinami N, Suzuki T, Yoshioka Y, Ochiya T, et al. Usefulness of serum microRNA as a predictive marker of recurrence and prognosis in biliary tract cancer after radical surgery. Sci Rep. 2019;9(1):5925.","journal-title":"Sci Rep"},{"key":"7289_CR19","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.omtn.2022.02.005","volume":"27","author":"MT Di Martino","year":"2022","unstructured":"Di Martino MT, Arbitrio M, Caracciolo D, Cordua A, Cuomo O, Grillone K, et al. MiR-221\/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: a systematic review. Mol Ther Nucleic Acids. 2022;27:1191\u2013224.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"5","key":"7289_CR20","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1002\/ijc.28563","volume":"135","author":"JW Yan","year":"2014","unstructured":"Yan JW, Lin JS, He XX. The emerging role of miR-375 in cancer. Int J Cancer. 2014;135(5):1011\u20138.","journal-title":"Int J Cancer"},{"key":"7289_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.154770","volume":"249","author":"BI Sukmana","year":"2023","unstructured":"Sukmana BI, Al-Hawary SIS, Abosaooda M, Adile M, Gupta R, Saleh EAM, et al. A thorough and current study of miR-214-related targets in cancer. Pathol Res Pract. 2023;249:154770.","journal-title":"Pathol Res Pract"},{"issue":"5","key":"7289_CR22","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/bjc.2011.29","volume":"104","author":"CB Lajer","year":"2011","unstructured":"Lajer CB, Nielsen FC, Friis-Hansen L, Norrild B, Borup R, Garn\u00e6s E, et al. Different miRNA signatures of oral and pharyngeal squamous cell carcinomas: a prospective translational study. Br J Cancer. 2011;104(5):830\u201340.","journal-title":"Br J Cancer"},{"issue":"12","key":"7289_CR23","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1016\/j.joms.2022.08.016","volume":"80","author":"X Xu","year":"2022","unstructured":"Xu X, Jin B, Cai L, Zhang Z, Ying Y, Luo J. Microrna-382-5p promotes oral squamous cell carcinoma development and progression by negatively regulating PTEN expression. J Oral Maxillofac Surg. 2022;80(12):2015\u201323.","journal-title":"J Oral Maxillofac Surg"},{"key":"7289_CR24","doi-asserted-by":"publisher","first-page":"e20240215","DOI":"10.1590\/1678-7757-2024-0215","volume":"32","author":"R Zhou","year":"2024","unstructured":"Zhou R, Chen Z, Cai Y, Zhang H, Mao S, Zhuang Y, et al. The simultaneous miR-155-5p overexpression and miR-223-3p Inhibition can activate pEMT in oral squamous cell carcinoma. J Appl Oral Sci. 2024;32:e20240215.","journal-title":"J Appl Oral Sci"},{"issue":"5","key":"7289_CR25","first-page":"580","volume":"6","author":"AJ Yoon","year":"2014","unstructured":"Yoon AJ, Wang S, Shen J, Robine N, Philipone E, Oster MW, et al. Prognostic value of miR-375 and miR-214-3p in early stage oral squamous cell carcinoma. Am J Transl Res. 2014;6(5):580\u201392.","journal-title":"Am J Transl Res"},{"issue":"1","key":"7289_CR26","first-page":"1919","volume":"17","author":"H Zheng","year":"2018","unstructured":"Zheng H, Li S. Reduced miRNA\u2013214 expression in oral mucosa contributes to the pathogenesis of oral lichen planus by targeting CD44. Mol Med Rep. 2018;17(1):1919\u201325.","journal-title":"Mol Med Rep"},{"issue":"1","key":"7289_CR27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11060-008-9688-0","volume":"91","author":"WJ Lukiw","year":"2009","unstructured":"Lukiw WJ, Cui JG, Li YY, Culicchia F. Up-regulation of micro-RNA-221 (miRNA-221; Chr Xp11.3) and caspase-3 accompanies down-regulation of the survivin-1 homolog BIRC1 (NAIP) in glioblastoma multiforme (GBM). J Neurooncol. 2009;91(1):27\u201332.","journal-title":"J Neurooncol"},{"issue":"7","key":"7289_CR28","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.31557\/APJCP.2021.22.7.2185","volume":"22","author":"F Bolandparva","year":"2021","unstructured":"Bolandparva F, Hashemi Nasab MS, Mohamadnia A, Garajei A, Farhadi Nasab A, Bahrami N. Early diagnosis of oral squamous cell carcinoma (OSCC) by miR-138 and miR-424-5p expression as a cancer marker. Asian Pac J Cancer Prev. 2021;22(7):2185\u20139.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"7","key":"7289_CR29","first-page":"3710","volume":"24","author":"H Zhang","year":"2020","unstructured":"Zhang H, Sun P, Wang YL, Yu XF, Tong JJ. MiR-214 promotes proliferation and inhibits apoptosis of oral cancer cells through MAPK\/ERK signaling pathway. Eur Rev Med Pharmacol Sci. 2020;24(7):3710\u20136.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"8","key":"7289_CR30","first-page":"615","volume":"35","author":"JB Han","year":"2020","unstructured":"Han JB, Huang ML, Li F, Yang R, Chen SM, Tao ZZ. MiR-214 mediates cell proliferation and apoptosis of nasopharyngeal carcinoma through targeting both WWOX and PTEN. Cancer Biother Radiopharm. 2020;35(8):615\u201325.","journal-title":"Cancer Biother Radiopharm"},{"issue":"4","key":"7289_CR31","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta delta C(T)) method. Methods. 2001;25(4):402\u20138.","journal-title":"Methods"},{"issue":"4","key":"7289_CR32","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s13402-012-0087-3","volume":"35","author":"MG Diniz","year":"2012","unstructured":"Diniz MG, Gomes CC, de Castro WH, Guimar\u00e3es AL, De Paula AM, Amm H, et al. miR-15a\/16\u2009\u2013\u20091 influences BCL2 expression in keratocystic odontogenic tumors. Cell Oncol (Dordr). 2012;35(4):285\u201391.","journal-title":"Cell Oncol (Dordr)"},{"issue":"1","key":"7289_CR33","doi-asserted-by":"publisher","first-page":"146","DOI":"10.4103\/jomfp.JOMFP_94_16","volume":"22","author":"TG Modi","year":"2018","unstructured":"Modi TG, Chalishazar M, Kumar M. Expression of Ki-67 in odontogenic cysts: a comparative study between odontogenic keratocysts, radicular cysts and dentigerous cysts. J Oral Maxillofac Pathol. 2018;22(1):146.","journal-title":"J Oral Maxillofac Pathol"},{"issue":"1","key":"7289_CR34","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nm.3026","volume":"19","author":"X Wang","year":"2013","unstructured":"Wang X, Guo B, Li Q, Peng J, Yang Z, Wang A, et al. Mir-214 targets ATF4 to inhibit bone formation. Nat Med. 2013;19(1):93\u2013100.","journal-title":"Nat Med"},{"issue":"4","key":"7289_CR35","first-page":"e491","volume":"24","author":"NB Fidele","year":"2019","unstructured":"Fidele NB, Yueyu Z, Zhao Y, Tianfu W, Liu J, Sun Y, et al. Recurrence of odontogenic keratocysts and possible prognostic factors: review of 455 patients. Med Oral Patol Oral Cir Bucal. 2019;24(4):e491\u2013501.","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"7289_CR36","doi-asserted-by":"publisher","first-page":"103850","DOI":"10.1016\/j.critrevonc.2022.103850","volume":"180","author":"GM Dar","year":"2022","unstructured":"Dar GM, Agarwal S, Kumar A, Nimisha, Apurva, Sharma AK, et al. A non-invasive miRNA-based approach in early diagnosis and therapeutics of oral cancer. Crit Rev Oncol Hematol. 2022;180:103850.","journal-title":"Crit Rev Oncol Hematol"},{"key":"7289_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911502","volume":"23","author":"A Menon","year":"2022","unstructured":"Menon A, Abd-Aziz N, Khalid K, Poh CL, Naidu R. MiRNA: a promising therapeutic target in cancer. Int J Mol Sci. 2022;23:19.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"7289_CR38","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/ijc.29041","volume":"136","author":"X Jiang","year":"2015","unstructured":"Jiang X, Du L, Wang L, Li J, Liu Y, Zheng G, et al. Serum microRNA expression signatures identified from genome-wide microRNA profiling serve as novel noninvasive biomarkers for diagnosis and recurrence of bladder cancer. Int J Cancer. 2015;136(4):854\u201362.","journal-title":"Int J Cancer"},{"issue":"1","key":"7289_CR39","doi-asserted-by":"publisher","first-page":"33","DOI":"10.21873\/anticanres.13077","volume":"39","author":"A Zembska","year":"2019","unstructured":"Zembska A, Jawiarczyk-Przyby\u0142owska A, Wojtczak B, Bolanowski M. Microrna expression in the progression and aggressiveness of papillary thyroid carcinoma. Anticancer Res. 2019;39(1):33\u201340.","journal-title":"Anticancer Res"},{"key":"7289_CR40","doi-asserted-by":"publisher","unstructured":"Lakhia R, Yheskel M, Flaten A, Ramalingam H, Aboudehen K, Ferr\u00e8 S, Biggers L, Mishra A, Chaney C, Wallace DP, Carroll T, Igarashi P, Patel V. Interstitial microRNA miR-214 attenuates inflammation and polycystic kidney disease progression. JCI Insight. 2020;5(7):e133785. PMID: 32182218; PMCID: PMC7205276. https:\/\/doi.org\/10.1172\/jci.insight.133785.","DOI":"10.1172\/jci.insight.133785"},{"issue":"6","key":"7289_CR41","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1590\/0103-6440202003350","volume":"31","author":"S Basuony","year":"2020","unstructured":"Basuony S, Hamed RS, Anti-Micro. RNA-221 a promising genetic therapy of oral squamous cell carcinoma (SCC-25). Braz Dent J. 2020;31(6):634\u20139.","journal-title":"Braz Dent J"},{"issue":"8","key":"7289_CR42","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1158\/1078-0432.CCR-08-3131","volume":"15","author":"M Avissar","year":"2009","unstructured":"Avissar M, Christensen BC, Kelsey KT, Marsit CJ. Microrna expression ratio is predictive of head and neck squamous cell carcinoma. Clin Cancer Res. 2009;15(8):2850\u20135.","journal-title":"Clin Cancer Res"},{"key":"7289_CR43","doi-asserted-by":"publisher","unstructured":"Tamas T, Raduly L, Berindan-Neagoe I, Dinu C, Botan E, Bumbu B, Tamas A, Stoia S, Leucuta DC, Bran S, Onisor F, B\u0103ciu\u021b G, Armencea G, B\u0103ciu\u021b M. The role of miRNA-221 and miRNA-34a in non-melanoma skin cancer of the head and neck region. Genes (Basel). 2023;14(2):503. PMID: 36833430; PMCID: PMC9956318.\u00a0 https:\/\/doi.org\/10.3390\/genes14020503.","DOI":"10.3390\/genes14020503"},{"issue":"1","key":"7289_CR44","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2174\/156652412798376170","volume":"12","author":"M Garofalo","year":"2012","unstructured":"Garofalo M, Quintavalle C, Romano G, Croce CM, Condorelli G. MiR221\/222 in cancer: their role in tumor progression and response to therapy. Curr Mol Med. 2012;12(1):27\u201333.","journal-title":"Curr Mol Med"},{"issue":"1","key":"7289_CR45","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1080\/21655979.2021.1932222","volume":"12","author":"S He","year":"2021","unstructured":"He S, Zhang W, Li X, Wang J, Chen X, Chen Y, et al. Oral squamous cell carcinoma (OSCC)-derived exosomal MiR-221 targets and regulates phosphoinositide-3-kinase regulatory subunit 1 (PIK3R1) to promote human umbilical vein endothelial cells migration and tube formation. Bioengineered. 2021;12(1):2164\u201374.","journal-title":"Bioengineered"},{"issue":"3","key":"7289_CR46","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/jop.13241","volume":"51","author":"L Yang","year":"2022","unstructured":"Yang L, Yang K, Wang H, Chen Y, Zhao J. LncRNA SCIRT absorbs miR-221 to advance the expression of LncRNA GAS5 in oral squamous cell carcinoma to inhibit cancer cell apoptosis. J Oral Pathol Med. 2022;51(3):256\u201362.","journal-title":"J Oral Pathol Med"},{"issue":"50","key":"7289_CR47","doi-asserted-by":"publisher","first-page":"18081","DOI":"10.1073\/pnas.0506216102","volume":"102","author":"N Felli","year":"2005","unstructured":"Felli N, Fontana L, Pelosi E, Botta R, Bonci D, Facchiano F, et al. Micrornas 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc Natl Acad Sci U S A. 2005;102(50):18081\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7289_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11070970","author":"G Ravegnini","year":"2019","unstructured":"Ravegnini G, Cargnin S, Sammarini G, Zanotti F, Bermejo JL, Hrelia P, et al. Prognostic role of miR-221 and miR-222 expression in cancer patients: a systematic review and meta-analysis. Cancers (Basel). 2019. https:\/\/doi.org\/10.3390\/cancers11070970.","journal-title":"Cancers (Basel)"},{"issue":"5","key":"7289_CR49","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.febslet.2013.01.016","volume":"587","author":"F Wang","year":"2013","unstructured":"Wang F, Liu M, Li X, Tang H. MiR-214 reduces cell survival and enhances cisplatin-induced cytotoxicity via down-regulation of Bcl2l2 in cervical cancer cells. FEBS Lett. 2013;587(5):488\u201395.","journal-title":"FEBS Lett"},{"issue":"2","key":"7289_CR50","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2217\/fon.14.193","volume":"11","author":"T Sharma","year":"2015","unstructured":"Sharma T, Hamilton R, Mandal CC. MiR-214: a potential biomarker and therapeutic for different cancers. Future Oncol. 2015;11(2):349\u201363.","journal-title":"Future Oncol"},{"issue":"7","key":"7289_CR51","doi-asserted-by":"publisher","first-page":"589","DOI":"10.2174\/1566524022666220428112744","volume":"23","author":"E Karimi","year":"2023","unstructured":"Karimi E, Dehghani A, Azari H, Zarei M, Shekari M, Mousavi P. Molecular mechanisms of miR-214 involved in cancer and drug resistance. Curr Mol Med. 2023;23(7):589\u2013605.","journal-title":"Curr Mol Med"},{"issue":"9","key":"7289_CR52","first-page":"11579","volume":"12","author":"N Deng","year":"2019","unstructured":"Deng N, Xu J. Expression of miR-214 and RASSF5 in oral cancer patients and their effects on apoptosis of oral cancer cells. Int J Clin Exp Med. 2019;12(9):11579\u201386.","journal-title":"Int J Clin Exp Med"},{"key":"7289_CR53","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/4589182","volume":"2022","author":"Y Yang","year":"2022","unstructured":"Yang Y, Sun X, Li M, Li L, Wang S, Zhu Y. Mir-214 modulates the growth and migration of oral cancer before and after chemotherapy through mediating ULK1. J Immunol Res. 2022;2022:4589182.","journal-title":"J Immunol Res"},{"issue":"22","key":"7289_CR54","doi-asserted-by":"publisher","first-page":"6509","DOI":"10.1111\/j.1742-4658.2009.07353.x","volume":"276","author":"NN Baroukh","year":"2009","unstructured":"Baroukh NN, Van Obberghen E. Function of microRNA-375 and microRNA-124a in pancreas and brain. FEBS J. 2009;276(22):6509\u201321.","journal-title":"FEBS J"},{"key":"7289_CR55","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/9704245","volume":"2020","author":"X Jia-Yuan","year":"2020","unstructured":"Jia-Yuan X, Wei S, Fang-Fang L, Zhi-Jian D, Long-He C, Sen L. Mir-375 inhibits the proliferation and invasion of nasopharyngeal carcinoma cells by suppressing PDK1. BioMed Res Int. 2020;2020:9704245.","journal-title":"BioMed Res Int"},{"key":"7289_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2021.106092","volume":"141","author":"J Xu","year":"2021","unstructured":"Xu J, Li B, Song W, Cao L, Zhu C, Lin S. Tumor suppressor functions of miRNA-375 in nasopharyngeal carcinoma through inhibition of ubiquitin-specific protease 1 expression. Int J Biochem Cell Biol. 2021;141:106092.","journal-title":"Int J Biochem Cell Biol"},{"issue":"7","key":"7289_CR57","doi-asserted-by":"publisher","first-page":"4503","DOI":"10.1007\/s12010-023-04375-3","volume":"195","author":"RK Moorthy","year":"2023","unstructured":"Moorthy RK, Srinivasan C, Kannan M, Arockiam AJV. Deregulation of miR-375 inhibits HOXA5 and promotes migration, invasion, and cell proliferation in breast cancer. Appl Biochem Biotechnol. 2023;195(7):4503\u201323.","journal-title":"Appl Biochem Biotechnol"},{"issue":"2","key":"7289_CR58","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jds.2021.09.020","volume":"17","author":"HF Tu","year":"2022","unstructured":"Tu HF, Lin LH, Chang KW, Cheng HW, Liu CJ. Exploiting salivary miR-375 as a clinical biomarker of oral potentially malignant disorder. J Dent Sci. 2022;17(2):659\u201365.","journal-title":"J Dent Sci"},{"issue":"4","key":"7289_CR59","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.13005\/bpj\/2781","volume":"16","author":"S Narasimhan","year":"2023","unstructured":"Narasimhan S, Narasimhan M, Shetty SR, Rajan ST, Al Kawas S, Subramani VN. Analyzing the expression of MicroRNA-375 and its target gene p53 in oral squamous cell carcinoma and its implication in oral carcinogenesis. Biomed Pharmacol J. 2023;16(4):2051\u201360.","journal-title":"Biomed Pharmacol J"},{"issue":"7","key":"7289_CR60","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1002\/cam4.1110","volume":"6","author":"Y Wu","year":"2017","unstructured":"Wu Y, Sun X, Song B, Qiu X, Zhao J. MiR-375\/SLC7A11 axis regulates oral squamous cell carcinoma proliferation and invasion. Cancer Med. 2017;6(7):1686\u201397.","journal-title":"Cancer Med"},{"issue":"8","key":"7289_CR61","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.molmed.2014.06.005","volume":"20","author":"J Hayes","year":"2014","unstructured":"Hayes J, Peruzzi PP, Lawler S. Micrornas in cancer: biomarkers, functions and therapy. Trends Mol Med. 2014;20(8):460\u20139.","journal-title":"Trends Mol Med"},{"key":"7289_CR62","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.canep.2018.12.008","volume":"58","author":"S Mazumder","year":"2019","unstructured":"Mazumder S, Datta S, Ray JG, Chaudhuri K, Chatterjee R. Liquid biopsy: miRNA as a potential biomarker in oral cancer. Cancer Epidemiol. 2019;58:137\u201345.","journal-title":"Cancer Epidemiol"},{"key":"7289_CR63","first-page":"94","volume":"4","author":"MB Kirschner","year":"2013","unstructured":"Kirschner MB, Edelman JJ, Kao SC, Vallely MP, van Zandwijk N, Reid G. The impact of hemolysis on Cell-Free MicroRNA biomarkers. Front Genet. 2013;4:94.","journal-title":"Front Genet"},{"issue":"4","key":"7289_CR64","doi-asserted-by":"publisher","first-page":"409","DOI":"10.2353\/jmoldx.2010.090155","volume":"12","author":"D Abdueva","year":"2010","unstructured":"Abdueva D, Wing M, Schaub B, Triche T, Davicioni E. Quantitative expression profiling in formalin-fixed paraffin-embedded samples by affymetrix microarrays. J Mol Diagn. 2010;12(4):409\u201317.","journal-title":"J Mol Diagn"}],"container-title":["BMC Oral Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-025-07289-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12903-025-07289-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-025-07289-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:27:26Z","timestamp":1781627246000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12903-025-07289-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7289"],"URL":"https:\/\/doi.org\/10.1186\/s12903-025-07289-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7298969\/v1","asserted-by":"object"}]},"ISSN":["1472-6831"],"issn-type":[{"value":"1472-6831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"5 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This in vitro study was approved by the Institutional Ethics Committee (IR.IAU.DENTAL.REC.1401.033).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1896"}}